We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Trending News

Icebergs floating in a blue sea.

Feedback Loop Melting West Antarctic Ice Sheet Uncovered

Two hands holding up a nasal spray, a packet of white pills and a tissue.

Common Antibiotic Shows Promise in the Treatment of Respiratory Viral Infections

Coral reef.

Exploring the Use of Nature-Based Solutions for Healthy Corals and Communities

Phage Therapies for Multidrug-Resistant Infections Should Consider Host Response

Supercomputer Simulation Unveils New Insights Into Membrane Fusion

Probing the Inner World of Cells Provides Unexpected Boost to Prime Editing

News

Agilent Technologies and BGI to Collaborate

Companies announce a collaborative effort to develop methodologies designated for next-generation genome-wide association studies. The methodologies will assist scientists pursuing disease and drug research.

NFI Orders BiOS Automated Biobanking System from Hamilton Storage Technologies

Large-scale system to provide long-term storage for one million crime scene DNA samples.

Biotools and 2B BlackBio Signs Agreement with Silanes Laboratories

Agreement on technology transfer and licensing of manufacturing of products in the fields of molecular diagnosis and personalized medicine.

Delivering RNA with Tiny Sponge-Like Spheres

New RNA interference method holds promise for treating cancer, other diseases.

Agilent and BGI to Collaborate on Next-Generation Super Array for Disease and Drug Research

Collaboration to create next-generation super exome, using Agilent’s SureSelect technology.

Dako Enters into an Additional Collaboration with Amgen

Collaboration on developing a companion diagnostic test for an investigational cancer therapy in clinical development.

Half Year Results - Mesoblast Posts Strong Cash Balance

Company reports cash reserves of $241 million for the 2012 financial half year reporting period.

Compugen Presents Prediction Based Discovery Strategy at “Targets and Strategies for Drug Discovery” Conference

Presentation includes disclosure of CGEN-15022 and CGEN-15092 as target candidates for antibody based cancer immunotherapy.

Yissum to Collaborate with BioConnections

The novel kits enable direct detection of "superbugs" and provide instant guidelines for appropriate treatment.

Mesoblast Half-Year Results

Strong financial position underpins company’s ability to deliver in increased value from broadened range of stem cell therapeutics.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter